Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CRANEWARE PLC Regulatory Filings 2018

Jan 31, 2018

7581_rns_2018-01-31_4fb2ceac-bd73-4fab-b210-c6803e2f6418.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5203D

Craneware plc

31 January 2018

Craneware plc

("Craneware" or the "Company")

Total Voting Rights

In accordance with the Disclosure and Transparency Rules, Craneware announces that at the date of this notice its issued share capital comprises 26,341,466 ordinary shares of 1p ("Ordinary Shares") each with voting rights.

No Ordinary Shares are held in treasury.

The total voting rights in the Company is therefore 26,341,466. The voting rights of all of the Ordinary Shares are identical.

The figure above may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Craneware, under the Disclosure and Transparency Rules.

For further information, please contact:

Craneware plc Peel Hunt Alma
+44 (0)131 550 3100 +44 (0)20 7418 8900 +44 (0)208 004 4217
Keith Neilson, CEO Dan Webster Caroline Forde
Craig Preston, CFO Adrian Trimmings

George Sellar
Hilary Buchanan

Robyn Fisher

About Craneware

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

Craneware is the leader in automated value cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Pittsburgh employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVRFKDDPQBKDFDN